SHANGHAI, June 1, 2026 /PRNewswire/ -- The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was held in Chicago from May 29 to June 2 (local time). As one of the world's leading oncology conferences, the ASCO Annual Meeting serves as a key venue for presenting advances in...
Hence then, the article about hengrui pharma presents more than 90 oncology studies at asco 2026 highlighting progress across multiple tumor types was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Hengrui Pharma Presents More Than 90 Oncology Studies at ASCO 2026, Highlighting Progress Across Multiple Tumor Types )
Also on site :
- Pulitzer-Winning Author’s Novel, Written in a Home Basement, Ranked ‘Greatest Book of the Last 20 Years’
- ‘Combine your passion with an investment strategy’: Meet the VC using 500,000 Pokémon and trading cards as a hedge against a debt crisis
- Do employers value University of Phoenix graduates? The Harris Poll survey finds 98% report satisfaction